ASPG and leukemia: Increased production of glutamine synthetase is suspected to reduce the efficacy of L-asparaginase, which is a chemotherapeutic agent that depletes glutamine and asparaginase, amino acids that are essential for leukemic cell survival, from the leukemia niche.